anti-CDH17-based antibody drug conjugates (ProAlt)

N/A

Report date: 2025/06/11 10:57:11

Base Information

Drug Nameanti-CDH17-based antibody drug conjugates (ProAlt)

Drug Alias NamePA-368BPA-368A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionIntegrin alpha2/beta1 antagonistsCadherin-17 modulatorsMetastasis inhibitors

TargetsCadherin-17Integrin alpha2/beta1

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProtein Alternatives Sl

China Registration ClassN/A

Develop Information

Active CompaniesProtein Alternatives Sl

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A